Dr. Jim Gilligan

The World Intellectual Property Organization (WIPO) has published clinical-stage biopharma Tryp Therapeutics Inc. (OTCQB: TRYPF)’s international patent application for the intravenous (IV) administration of psilocybin and psilocin.  The “Improved Methods For The Use of Psychedelics...

Psilocybin, the active ingredient in “magic mushrooms,” could be part of the solution for people struggling with binge eating disorder, a condition characterized by recurring episodes of eating large quantities of food and feeling unable to stop. Tryp Therapeutics, Inc. (OTCQB: TRYPF),...